Artificial intelligence and the future of global health

Искусственный интеллект и будущее глобального здравоохранения
Brian Wahl, Nina Schwalbe
2020-05-01

artificial intelligencedisease outbreak predictionglobal healthlow- and middle-income countriesmachine learning
Concurrent advances in information technology infrastructure and mobile computing power in many low and middle-income countries (LMICs) have raised hopes that artificial intelligence (AI) might help to address challenges unique to the field of global health and accelerate achievement of the health-related sustainable development goals. A series of fundamental questions have been raised about AI-driven health interventions, and whether the tools, methods, and protections traditionally used to make ethical and evidence-based decisions about new technologies can be applied to AI. Deployment of AI has already begun for a broad range of health issues common to LMICs, with interventions focused primarily on communicable diseases, including tuberculosis and malaria. Types of AI vary, but most use some form of machine learning or signal processing. Several types of machine learning methods are frequently used together, as is machine learning with other approaches, most often signal processing. AI-driven health interventions fit into four categories relevant to global health researchers: (1) diagnosis, (2) patient morbidity or mortality risk assessment, (3) disease outbreak prediction and surveillance, and (4) health policy and planning. However, much of the AI-driven intervention research in global health does not describe ethical, regulatory, or practical considerations required for widespread use or deployment at scale. Despite the field remaining nascent, AI-driven health interventions could lead to improved health outcomes in LMICs. Although some challenges of developing and deploying these interventions might not be unique to these settings, the global health community will need to work quickly to establish guidelines for development, testing, and use, and develop a user-driven research agenda to facilitate equitable and ethical use.
1
AI-driven health interventions are already being deployed in LMICs, primarily for communicable diseases such as tuberculosis and malaria.
2
Advances in information infrastructure and mobile computing have increased expectations that AI can address LMIC-specific health challenges and support health-related Sustainable Development Goals.
3
Although the field remains nascent, AI could improve LMIC health outcomes; rapid development of guidelines and a user-driven research agenda are needed for equitable and ethical implementation.
4
Global-health AI applications fall into four categories: diagnosis, morbidity or mortality risk assessment, outbreak prediction and surveillance, and health policy and planning.
5
Machine learning and signal processing are the predominant AI approaches, often combined with multiple machine-learning methods or other techniques.
6
Most global-health AI research insufficiently addresses the ethical, regulatory, and practical requirements for widespread and scalable deployment.

AI-driven health interventions in low- and middle-income countries (LMICs)

Their applications, evidence, and ethical, regulatory, and practical requirements for equitable large-scale deployment across diagnosis, risk assessment, outbreak surveillance, and health policy and planning

Publication Details
Publication Date
2020-05-01
Journal
Publisher
ISSN
Cited by
907
Access Type
Author Information
Authors
Brian Wahl
Nina Schwalbe
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%